Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen

Microbes and Infection

Volumn 4, Issue 8, 2002, Pages 815-820

  Lavigne, María Victoria ^a   Castro, Marisa ^a   Mateo, Nancy ^b   Deluchi, Silvana ^b   Atzori, Carlos ^b   Piudo, Luciana ^b   Calcagno, María ^a   Brero, María Luisa ^b   Manghi, Marcela ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centro Nacional De Control De Calidad De Biológicos Dr CG Malbrán   (Argentina)

Author keywords

DTP vaccination; Immune response modulation; Particulate antigens; Tetanus immune response

Indexed keywords

ANTIBODY; ANTIGEN; DIPHTHERIA TOXOID; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 12; INTERLEUKIN 5; TETANUS ANTIBODY; TETANUS TOXOID; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BORDETELLA PERTUSSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INFLAMMATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CROSS REACTIONS; CYTOKINES; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; MICE; MICE, INBRED BALB C; SOLUBILITY; TETANUS TOXOID; TH1 CELLS; TH2 CELLS; VACCINATION; WHOOPING COUGH;

BORDETELLA; BORDETELLA PERTUSSIS;

EID: 0036629799     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01601-5     Document Type: Article

References (27)

1. Gajewski T.F., Pinnas M., Wong T., Fitch F.W. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen presenting cell populations. J. Immunol. 146:1991;1750-1758.
2. Schmitz J., Radbruch A. Distinct antigen presenting cell derived signals induce Th cell proliferation and expression of effector cytokines. Int. Immunol. 4:1992;43-51.
3. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.
4. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
5. Dal Monte P., Szoka F. Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes. Vaccine. 7:1989;401-408.
6. Dal Monte P., Szoka F. Effect of liposome encapsulation on antigen presentation in vitro. J. Immunol. 142:1989;1437-1443.
7. Redhead K., Watkins J., Barnard A., Mills K.H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:1993;3190-3198.
8. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology. 8:1996;372-380.
9. Zepp F., Knuf M., Habermehl P., Schmitt H.J., Rebsch C., Schmidtke P., Clemens R., Slaoui M. Pertussis-specific cell mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:1996;4078-4084.
10. Ausiello C., Urbani F., La Sala A., Lande R., Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:1997;2168-2174.
11. Ryan M., Gothefors L., Storsaeter J., Mills K.H. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev. Biol. Stand. 89:1997;297-305.
12. Mills K., Ryan M., Ryan E., Mahon B. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:1998;594-602.
13. Ryan M., Murphy G., Ryan E., Nilsson L., Schackley F., Gothefors L., Oymar K., Miller E., Storsaeter J., Mills K.H.G. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology. 93:1998;1-10.
14. McGuirk P., Mills K.H. A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing Pertussis vaccines. Infect. Immun. 68:2000;1383-1390.
15. Craig J.P. Rose N.R., Conway de Macario E., Fahey J.L., Friedman H., Penn G.M., Manual of Laboratory Immunology. 1992;435-439 American Society for Microbiology, Washington, DC.
16. Finney D.J. Statistical Methods in Biological Assay. 1964;33 Griffin, London.
17. Tanaka T., Katada Y., Higa S., Fujiwara H., Wang W., Saeki Y., Ohshima S., Okuda Y., Suemura M., Kishimoto T. Enhancement of T helper2 response in the absence of interleukin (IL-)6; an inhibition of IL-4-mediated T helper2 cell differentiation by IL-6. Cytokine. 13:2001;193-201.
18. Leal I., Smedegård B., Andersen P., Appelberg R. Interleukin-6 and Interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a Tuberculosis subunit vaccine. Infect. Immun. 67:1999;5747-5754.
19. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 68:2000;3322-3326.
20. Canthaboo C., Williams L., Xing D., Corbel M.J. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine. 19:2000;637-643.
21. Trincheri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
22. Brewer J.M., Tetley L., Richmond J., Liew F.Y., Alexander J. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J. Immunol. 161:1998;4000-4007.
23. Grüber C., Lau S., Dannemann A., Sommerfeld C., Wahn U., Aalberse R. Down-regulation of IgE and IgG4 antibodies to tetanus and diphteria toxoid by co-vaccination with cellular Bordetella pertussis vaccine. J. Immunol. 167:2001;2411-2417.
24. Van Snick J. Interleukin-6: an overview. Annu. Rev. Immunol. 8:1990;253-278.
25. Stein B., Sutherland M.S.K. IL-6 as a drug discovery target. Drug Discovery Today. 3:1998;202-213.
26. Njamkepo E., Rimlinger F., Thiberge S., Guiso N. Thirty-five years' experience with the whole-cell vaccine in France: vaccine strains and immunogenicity. Vaccine. 20:2002;1290-1294.
27. Fletcher M.A., Saliou P., Ethevenaux C., Plotkin S.A. The efficacy of whole cell pertussis immunization: collected data on a vaccine produced in France. Public Health. 115:2001;119-129.